Abstract
We have read “Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease” by Lindahl and colleagues with great interest, and congratulate the authors for their accurate analysis of this large population of patients with myocardial infarction with nonobstructive coronary arteries (MINOCA).1 They retrospectively selected patients with MINOCA from the SWEDEHEART registry (the Swedish Web-system for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies) thus obtaining a prevalence of 8.0%. For the first time, they clearly demonstrated an improvement in the prognosis of this population over …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
